| Armida Parala-metz, MD | |
|
1021 Morehead Medical Dr, Ste A, Charlotte, NC 28204-2990 | |
| (980) 442-2000 | |
| Not Available |
| Full Name | Armida Parala-metz |
|---|---|
| Gender | Female |
| Speciality | Hospice/palliative Care |
| Experience | 26 Years |
| Location | 1021 Morehead Medical Dr, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013136308 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atrium Health At Home Charlotte | Charlotte, NC | Home health agency |
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Charlotte-mecklenburg Hospital Authority | 2961310685 | 488 |
News Archive
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the U.S. Food and Drug Administration has granted multiple Orphan Drug Designations for the Company's lead drug candidate, aldoxorubicin, in three indications: glioblastoma multiforme (GBM), small cell lung cancer and ovarian cancer.
Adaptimmune announced today that it has opened a Phase I/IIa, multiple-site, two-cohort, open-label clinical trial in ovarian cancer at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif.
Mayo Clinic's campus in Florida has entered into a collaborative and sponsored research agreement with SK Biopharmaceuticals of Seoul, South Korea, with the goal of developing new treatments for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The collaboration marks a new approach to combating a disease that has proved difficult to treat in recent clinical trials.
An 'exhausted' army of immune cells may not be able to fight off infection, but if its soldiers fight too hard they risk damaging the very body they are meant to be protecting, suggests new research from the University of Cambridge.
› Verified 9 days ago
| Entity Name | The Charlotte-mecklenburg Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605 |
News Archive
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the U.S. Food and Drug Administration has granted multiple Orphan Drug Designations for the Company's lead drug candidate, aldoxorubicin, in three indications: glioblastoma multiforme (GBM), small cell lung cancer and ovarian cancer.
Adaptimmune announced today that it has opened a Phase I/IIa, multiple-site, two-cohort, open-label clinical trial in ovarian cancer at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif.
Mayo Clinic's campus in Florida has entered into a collaborative and sponsored research agreement with SK Biopharmaceuticals of Seoul, South Korea, with the goal of developing new treatments for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The collaboration marks a new approach to combating a disease that has proved difficult to treat in recent clinical trials.
An 'exhausted' army of immune cells may not be able to fight off infection, but if its soldiers fight too hard they risk damaging the very body they are meant to be protecting, suggests new research from the University of Cambridge.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Armida Parala-metz, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Armida Parala-metz, MD 1021 Morehead Medical Dr, Ste A, Charlotte, NC 28204-2990 Ph: (980) 442-2000 |
News Archive
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the U.S. Food and Drug Administration has granted multiple Orphan Drug Designations for the Company's lead drug candidate, aldoxorubicin, in three indications: glioblastoma multiforme (GBM), small cell lung cancer and ovarian cancer.
Adaptimmune announced today that it has opened a Phase I/IIa, multiple-site, two-cohort, open-label clinical trial in ovarian cancer at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif.
Mayo Clinic's campus in Florida has entered into a collaborative and sponsored research agreement with SK Biopharmaceuticals of Seoul, South Korea, with the goal of developing new treatments for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The collaboration marks a new approach to combating a disease that has proved difficult to treat in recent clinical trials.
An 'exhausted' army of immune cells may not be able to fight off infection, but if its soldiers fight too hard they risk damaging the very body they are meant to be protecting, suggests new research from the University of Cambridge.
› Verified 9 days ago
Dr. Anish Kaushik Vani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 125 Queens Rd Ste 200, Charlotte, NC 28204 Phone: 704-343-9800 Fax: 704-347-2011 | |
John Michael Fedor, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1237 Harding Pl, Ste 3100, Charlotte, NC 28204 Phone: 704-373-0212 | |
Dr. Michael Warren Smith, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6115 Park South Dr Ste 100, Charlotte, NC 28210 Phone: 704-554-8787 Fax: 704-554-8774 | |
William Lane Jr., MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1350 S Kings Dr, Charlotte, NC 28207 Phone: 704-446-4490 | |
Dr. Alagusivakumari Rameshbabu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10648 Park Rd, Charlotte, NC 28210 Phone: 704-667-8050 | |
Shibin Thomas Jacob, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 E W T Harris Blvd, Bldg 5000 Suite #5101, Charlotte, NC 28262 Phone: 704-863-5847 | |
Oscar Sven Brann, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6060 Piedmont Row Dr S Fl 10, Charlotte, NC 28287 Phone: 704-489-3094 |